Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock

<p>BRISBANE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (NASDAQ: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced the pricing of an underwritten public offering of 25,035,000 shares of its common stock and pre-funded warrants to purchase 18,379,861 […]</p>
<p>The post <a href="https://forextv.com/top-news/annexon-announces-pricing-of-125-0-million-underwritten-public-offering-of-common-stock/">Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>